map Central

Advisory on Strengthening Enforcement against Unauthorized Promotion and Distribution of GLP-1 Based Drugs

Updated on:27th Mar, 2026
The Central Drug Standard Control Organization vide F. No. Enforc-11021(11)/34/2026-eoffice-Part(1), issued Advisory on Strengthening Enforcement against Unauthorized Promotion and Distribution of GLP-1 Based Drugs. Please refer the advisory for more details.
Download download
PREVIOUS
Advisory regarding Use of Cosmetics, Prohibited Ingredients and Misleading Claims
NEXT
Notifications regarding Revised Standards for Telecommunication Equipment under the Telecommunication Act, 2023